Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2000
06/29/2000DE19860759A1 Special plaster for disinfecting the skin before an injection comprises a medically active carrier with disinfectant which by application of pressure is made to run out onto the injection zone of the skin
06/29/2000DE19860132A1 Use of allergens or allergenic vaccines in the treatment of allergies
06/29/2000DE19859910A1 Cyclosporin-Lösung Cyclosporin solution
06/29/2000DE19859636A1 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff A controlled release pharmaceutical composition comprising as an active ingredient tilidine mesylate
06/29/2000DE19859499A1 Stable ginger extract preparations useful for treating dyspepsia or travel sickness, contain oil, triglyceride or fatty acid or alcohol as stabilizing auxiliary
06/29/2000DE19859231A1 Schäumende Antacida-Suspensionstabletten Foaming antacid suspension tablets
06/29/2000DE19859045A1 Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung Emulsion of oil in water with a protective effect against peroxidation of human organs, their preparation and use
06/29/2000CA2357413A1 Sensitizing agents for the treatment of skin lesions
06/29/2000CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
06/29/2000CA2355848A1 Dihydropyrimidines and uses thereof
06/29/2000CA2355820A1 Novel formulations comprising lipid-regulating agents
06/29/2000CA2355696A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
06/29/2000CA2355627A1 Foaming antacid suspension tablets
06/29/2000CA2355368A1 Cgmp pde 5 inhibitors for inhalation in the treatment of sexual dysfunction
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000CA2352624A1 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans
06/29/2000CA2352535A1 Method for preparing suspension of stable posiplexes
06/29/2000CA2293729A1 Nanocapsules based on polyalkylene adipate, the process of preparing them, and cosmetic or dermatological compounds containing them
06/29/2000CA2293177A1 Nanoemulsion based on ethoxylate fatty ethers or ethoxylate fatty esters, and its utilizations in cosmetics, dermatology and/or ophthalmology
06/28/2000EP1013777A1 Powdered dextrose and method for preparing same
06/28/2000EP1013772A1 Method for preparing suspension of stable posiplexes
06/28/2000EP1013734A1 Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same
06/28/2000EP1013338A1 Nanoemulsion based on fatty esters of phosphoric acid and uses thereof in the fields of cosmetics, dermatology, pharmaceuticals and/or ophthalmology
06/28/2000EP1013302A1 Implant system
06/28/2000EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013286A2 Vitamin preparation, process for production and use thereof
06/28/2000EP1013277A1 Freeze-dried preparations and process for producing the same
06/28/2000EP1013274A2 Composition comprising amoxycillin and clavulanic acid
06/28/2000EP1013273A1 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
06/28/2000EP1013271A2 Nimodipine tablets
06/28/2000EP1013270A2 Controlled release growth hormone containing microspheres
06/28/2000EP1013269A1 Improvement in medicament administration system
06/28/2000EP1013268A1 Compositions containing liposomes and/or emulsions and process for the preparation thereof
06/28/2000EP1013267A1 O/W emulsions with a high wax content and its uses in cosmetics and dermatology
06/28/2000EP1013176A1 Sugar and/or sugar alcohol containing matrix material and method for preparing the same
06/28/2000EP1013175A1 Sugarfree candied product
06/28/2000EP1012331A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
06/28/2000EP1012208A1 Cross-linked particles
06/28/2000EP1012204A1 Spherical microparticles containing linear polysaccharides
06/28/2000EP1011854A1 Method for producing aqueous emulsions or suspensions
06/28/2000EP1011767A1 Device for administering insulin in controlled dosages by controlling total inhaled volume
06/28/2000EP1011743A1 Loading and release of water-insoluble drugs
06/28/2000EP1011735A1 METHOD OF $i(IN VIVO) TRANSFORMATION UTILIZING LIPID VEHICLES
06/28/2000EP1011728A1 Prostaglandin product
06/28/2000EP1011727A1 Viscous hemostatic composition, in particular in gel state
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011721A1 Vaginal lactobacillus medicant
06/28/2000EP1011720A2 Mucosal cytotoxic t lymphocyte responses
06/28/2000EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders
06/28/2000EP1011693A1 Use of locally delivered metal ions for treatment of periodontal disease
06/28/2000EP1011690A1 Cross-linked polysaccharide drug carrier
06/28/2000EP1011688A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
06/28/2000EP1011684A2 Solid oral dosage form comprising a combination of metformin and glibenclamide
06/28/2000EP1011680A2 Controlled release microsphere delivery system
06/28/2000EP1011674A1 Transdermal therapeutic system containing the active substance scopolamine base
06/28/2000EP1011657A1 Nitric oxide inhibits rhinovirus infection
06/28/2000EP1011647A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
06/28/2000EP1011646A1 Pharmaceutical compositions and devices for their administration
06/28/2000EP1011644A1 Methods and apparatus for treatment of parkinson's disease
06/28/2000EP1011643A1 Chewing gum containing controlled release acyclic carboxamides
06/28/2000EP1011642A2 Osmotic delivery system with semipermeable plug
06/28/2000EP1011640A1 Solid pharmaceutical dosage forms in form of a particulate dispersion
06/28/2000EP1011639A1 Bright white film coatings and film coating compositions therefor
06/28/2000EP1011638A1 Small particle liposome aerosols for delivery of anti-cancer drugs
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011636A1 New foam-forming pharmaceutical composition
06/28/2000EP1011635A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
06/28/2000EP1011634A1 Preparation of pharmaceutical compositions
06/28/2000EP1011633A1 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
06/28/2000EP1011632A2 A pharmaceutical composition for treating dysmenorrhea and premature labor
06/28/2000EP1011631A1 Antacid composition
06/28/2000EP1011620A1 CELLULOSE BINDING DOMAINS (CBDs) FOR ORAL CARE PRODUCTS
06/28/2000EP1011610A1 Skin care compositions and use
06/28/2000EP1011567A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
06/28/2000EP1011518A1 Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method for preparation thereof
06/28/2000EP1011457A1 Stent lining
06/28/2000EP1011440A1 Vaccine against lipopolysaccharide core
06/28/2000EP1011327A1 Treatment or prophylaxis of retinal pathology and spinal cord injury
06/28/2000EP0732918B1 Benzalkonium fluoride injectable solution
06/28/2000EP0715520B1 Use of a suspension based on sucralphate gel as antacid
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000EP0689419B2 Cosmetic or topical use of an aqueous dispersion based on non-volatile organopolysiloxanes and an acrylamide or homopolymeric copolymer type cross-linked methacryloyloxyethyl trimethylammonium chloride polymer
06/28/2000CN2384621Y Wet application bone fracture plaster
06/28/2000CN1258229A Betaine product, method for its manufacture, and its use
06/28/2000CN1258220A Pharmaceutical compositions comprising cyclodextrins
06/28/2000CN1258218A Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof
06/28/2000CN1258217A Pharmaceutical formulation of omeprazole
06/28/2000CN1258215A Serine protease and topical retinoid composition
06/28/2000CN1258198A Utilisations of oil bodies
06/28/2000CN1258191A Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
06/28/2000CN1257735A Medicine for treating constipation and its preparing process
06/28/2000CN1257723A Medicine for dissolving and discharging calculi by omphalotherapy
06/28/2000CN1257721A Liquid medicine for giving up smoking and its preparing process
06/28/2000CN1257716A Pudendum-cleaning hygienic cream
06/28/2000CN1257715A Tincture for treating rheumatoid arthritis and its preparing process
06/28/2000CN1257711A Liquid medicine for treating beriberi
06/28/2000CN1257710A Anti-hepatitis-B-virus injection
06/28/2000CN1257707A Health-care medicine for improving vitality of old people and its prescription
06/28/2000CN1257705A Flowable drug precursor product for compressing tablet, pill and coated tablet, and preparing method thereof
1 ... 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 ... 2991